High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009.

The prevalence of antibodies reactive to the 2009 pandemic influenza A(H1N1) was determined in sera collected before the start of the pandemic, during the early phase, and after the main epidemic wave and nationwide vaccination campaign in Norway. A substantial rise in prevalence of antibodies at protective titres, from 3.2% to 44.9%, was observed between August 2009 and January 2010. The highest prevalence, 65.3%, was seen in the age group of 10-19 year-olds.

[1]  J. Dowling,et al.  General practice out-of-hours co-operatives--population contact rates. , 2006, Irish medical journal.

[2]  N. Andrews,et al.  Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study , 2010, The Lancet.

[3]  Brendan Giles,et al.  Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza , 2010, PLoS currents.

[4]  L. Haaheim.  Surveillance of the antibody status to current influenza strains in the Norwegian population. 2: Antibodies to the A/USSR/90/77 (H1N1) virus in various age groups after the second epidemic wave. , 1980, NIPH annals.

[5]  N. Verlander,et al.  Evaluation of syndromic surveillance based on National Health Service Direct derived data--England and Wales. , 2005, MMWR supplements.

[6]  Pan Xin,et al.  Novel Swine-Origin Influenza A(H1N1) Virus , 2009 .

[7]  M. Coory,et al.  Assessment of ambulance dispatch data for surveillance of influenza-like illness in Melbourne, Australia , 2009, Public Health.

[8]  Richard Platt,et al.  Telephone Triage Service Data for Detection of Influenza-Like Illness , 2009, PloS one.

[9]  D. Henderson,et al.  Original Antigenic Sin and Pandemic (H1N1) 2009 , 2010, Emerging infectious diseases.

[10]  S. Ostroff,et al.  Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza. , 2010, PLoS currents.

[11]  E. D. Kilbourne,et al.  Induction of Partial Specific Heterotypic Immunity in Mice by a Single Infection with Influenza A Virus , 1965, Journal of bacteriology.

[12]  L. Finelli,et al.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.

[13]  Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus. , 2010, Releve epidemiologique hebdomadaire.

[14]  K. Moore,et al.  Using Ontario's "Telehealth" health telephone helpline as an early-warning system: a study protocol , 2006, BMC Health Services Research.

[15]  R K Griffiths,et al.  Can calls to NHS Direct be used for syndromic surveillance? , 2001, Communicable disease and public health.

[16]  E. Koay,et al.  Tracking the emergence of pandemic Influenza A/H1N1/2009 and its interaction with seasonal influenza viruses in Singapore. , 2010, Annals of the Academy of Medicine, Singapore.

[17]  M. Coory,et al.  Influenza-like illness surveillance using a deputising medical service corresponds to surveillance from sentinel general practices. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  Michael M. Wagner,et al.  Telephone Triage: A Timely Data Source for Surveillance of Influenza-like Diseases , 2003, AMIA.

[19]  Haaheim Lr.  Surveillance of the antibody status to current influenza strains in the Norwegian population. 1: Method of serum sampling and evaluation of the A/USSR/77 (H1N1) impact in various age groups in 1978. , 1979 .

[20]  C. Robertson,et al.  2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  D. Henderson,et al.  Original Antigenic Sin and Pandemic (H1N1) 2009 , 2010, Emerging infectious diseases.

[22]  S. Salmaso,et al.  Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. , 2010, Vaccine.

[23]  G E Smith,et al.  Use of NHS Direct calls for surveillance of influenza--a second year's experience. , 2002, Communicable disease and public health.

[24]  J. Yewdell,et al.  Heterosubtypic immunity to influenza A virus: where do we stand? , 2008, Microbes and infection.

[25]  S. Larrieu,et al.  Performance of a syndromic system for influenza based on the activity of general practitioners, France. , 2009, Journal of public health.

[26]  Y. Elbert,et al.  Disease outbreak detection system using syndromic data in the greater Washington DC area. , 2002, American journal of preventive medicine.

[27]  K. Moore,et al.  Can Telehealth Ontario respiratory call volume be used as a proxy for emergency department respiratory visit surveillance by public health? , 2008, CJEM.

[28]  C. Rodriguez,et al.  New York City syndromic surveillance systems. , 2004, MMWR supplements.

[29]  N. Ferguson,et al.  Influenza evolution and immune selection , 2004 .

[30]  N Q Verlander,et al.  Can syndromic thresholds provide early warning of national influenza outbreaks? , 2008, Journal of public health.

[31]  L. Haaheim.  Surveillance of the antibody status to current influenza strains in the Norwegian population. 1: Method of serum sampling and evaluation of the A/USSR/77 (H1N1) impact in various age groups in 1978. , 1979, NIPH annals.

[32]  N. Verlander,et al.  A national syndromic surveillance system for England and Wales using calls to a telephone helpline. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[33]  N. Ferguson,et al.  Ecological and immunological determinants of influenza evolution , 2003, Nature.

[34]  Shirley Large,et al.  Tracking the spatial diffusion of influenza and norovirus using telehealth data: A spatiotemporal analysis of syndromic data , 2008, BMC medicine.